Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment
Glioblastoma multiforme is the most common and malignant primary tumor of the central nervous system. Despite the existing modern complex therapy and advances in the study of molecular genetic changes in this tumor, the prognosis for patients with glioblastoma is one of the most unfavorable in oncol...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-11-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/380 |
| _version_ | 1797759418468663296 |
|---|---|
| author | G. P. Guens V. D. Sanikovich V. A. Mileyko A. A. Lebedeva |
| author_facet | G. P. Guens V. D. Sanikovich V. A. Mileyko A. A. Lebedeva |
| author_sort | G. P. Guens |
| collection | DOAJ |
| description | Glioblastoma multiforme is the most common and malignant primary tumor of the central nervous system. Despite the existing modern complex therapy and advances in the study of molecular genetic changes in this tumor, the prognosis for patients with glioblastoma is one of the most unfavorable in oncology. This overview reviews existing therapeutic agents and clinical studies of potential drugs for the treatment of patients with glioblastoma multiforme.Next-generation sequencing has become firmly established in the clinical practice of oncologists and allows detecting gene mutations in tumor cells, some of which can serve as targets for therapy. Glioblastoma is characterized by a large number of potentially targeted molecular genetic disorders. As in the case of other solid tumors, targeted and immunotherapy for glioblastomas is being actively studied, including the combination of drugs with physical methods of exposure. To date, new treatment methods of glioblastoma, including antiangiogenic therapy, immunotherapy, oncolytic viral therapy and gene therapy still have uncertain or very modest clinical results. There are many reasons for the lack of progress in the treatment of glioblastoma – from the banal inability of most molecules to overcome the blood-brain barrier to the wide genetic heterogeneity of these tumors. The most promising direction of studies is immunotherapy. But at this stage, we cannot say that there is an effective monotherapy for glioblastoma. The combination treatment with radiation therapy and chemotherapy increases the mutational load, the expression of stress and other factors, therefore, the researchers pin great hopes on the combined methods of treatment. |
| first_indexed | 2024-03-12T18:44:11Z |
| format | Article |
| id | doaj.art-d816044babf6417a87fe65b695eb9875 |
| institution | Directory Open Access Journal |
| issn | 2313-805X 2413-3787 |
| language | Russian |
| last_indexed | 2024-03-12T18:44:11Z |
| publishDate | 2021-11-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Успехи молекулярной онкологии |
| spelling | doaj.art-d816044babf6417a87fe65b695eb98752023-08-02T07:48:01ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872021-11-0183607610.17650/2313-805X-2021-8-3-60-76218Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatmentG. P. Guens0V. D. Sanikovich1V. A. Mileyko2A. A. Lebedeva3Кафедра онкологии и лучевой терапии ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииКафедра онкологии и лучевой терапии ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииООО «Онкодиагностика Атлас»ООО «Онкодиагностика Атлас»Glioblastoma multiforme is the most common and malignant primary tumor of the central nervous system. Despite the existing modern complex therapy and advances in the study of molecular genetic changes in this tumor, the prognosis for patients with glioblastoma is one of the most unfavorable in oncology. This overview reviews existing therapeutic agents and clinical studies of potential drugs for the treatment of patients with glioblastoma multiforme.Next-generation sequencing has become firmly established in the clinical practice of oncologists and allows detecting gene mutations in tumor cells, some of which can serve as targets for therapy. Glioblastoma is characterized by a large number of potentially targeted molecular genetic disorders. As in the case of other solid tumors, targeted and immunotherapy for glioblastomas is being actively studied, including the combination of drugs with physical methods of exposure. To date, new treatment methods of glioblastoma, including antiangiogenic therapy, immunotherapy, oncolytic viral therapy and gene therapy still have uncertain or very modest clinical results. There are many reasons for the lack of progress in the treatment of glioblastoma – from the banal inability of most molecules to overcome the blood-brain barrier to the wide genetic heterogeneity of these tumors. The most promising direction of studies is immunotherapy. But at this stage, we cannot say that there is an effective monotherapy for glioblastoma. The combination treatment with radiation therapy and chemotherapy increases the mutational load, the expression of stress and other factors, therefore, the researchers pin great hopes on the combined methods of treatment.https://umo.abvpress.ru/jour/article/view/380глиобластоматаргетная терапияиммунотерапияновые терапевтические стратегии |
| spellingShingle | G. P. Guens V. D. Sanikovich V. A. Mileyko A. A. Lebedeva Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment Успехи молекулярной онкологии глиобластома таргетная терапия иммунотерапия новые терапевтические стратегии |
| title | Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment |
| title_full | Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment |
| title_fullStr | Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment |
| title_full_unstemmed | Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment |
| title_short | Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment |
| title_sort | glioblastoma a molecular genetic portrait and modern therapeutic strategies for drug treatment |
| topic | глиобластома таргетная терапия иммунотерапия новые терапевтические стратегии |
| url | https://umo.abvpress.ru/jour/article/view/380 |
| work_keys_str_mv | AT gpguens glioblastomaamoleculargeneticportraitandmoderntherapeuticstrategiesfordrugtreatment AT vdsanikovich glioblastomaamoleculargeneticportraitandmoderntherapeuticstrategiesfordrugtreatment AT vamileyko glioblastomaamoleculargeneticportraitandmoderntherapeuticstrategiesfordrugtreatment AT aalebedeva glioblastomaamoleculargeneticportraitandmoderntherapeuticstrategiesfordrugtreatment |